[Form 4] Cyclacel Pharmaceuticals, Inc. Insider Trading Activity

Rhea-AI Filing Summary

FITTERS Diversified Berhad, a director, reported a sale of $5.293-per-share common stock on 10/08/2025 for 142,000 shares, reducing its stake to 557,158 shares held directly. The Form 4 shows the transaction type as a sale and lists the reporting person’s address in Kuala Lumpur. The form was signed by Datuk Tan Chor How Christopher on 10/10/2025.

Positive

• Continued direct ownership of 557,158 shares by the reporting person after the sale
• Transparent disclosure of sale price ($5.293) and share count, meeting Section 16 reporting requirements

Negative

• Disposition of 142,000 shares reduces the insider's stake and increases public float
• Sale occurred without accompanying explanation of purpose or plan in the filing

Insights

Corporate Governance Analyst

Director executed a material share sale, but retains a meaningful stake.

The filing documents a director-level sale of 142,000 shares at $5.293, leaving 557,158 shares owned directly. Such disclosures are routine compliance items that inform investors about insider liquidity and ownership continuity.

Key dependencies include future Form 4 filings for additional trades and any scheduled lockups or agreements; monitor subsequent filings within 30 days for pattern changes.

Equity Markets Analyst

Sale reduces insider holding but not a controlling shift in ownership.

The reported disposition lowers the insider position by a quantifiable amount (142,000 shares) at a disclosed price, which may modestly increase public float. The remaining 557,158 shares indicate continued alignment with shareholder interests.

Watch for additional trades or scheduled plans that would affect float or signal a change in insider confidence over the next several weeks.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FITTERS Diversified Berhad

(Last) (First) (Middle)

NO. 1, JALAN TEMBAGA SD 5/2

BANDAR SRI DAMANSARA

(Street)

KUALA LUMPUR N8 52200

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bio Green Med Solution, Inc. [ BGMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/08/2025		S		142,000	D	$5.293	557,158	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Datuk Tan Chor How Christopher	10/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for BGMS report on 10/08/2025?

The Form 4 reports that FITTERS Diversified Berhad sold 142,000 shares of BGMS at $5.293, leaving 557,158 shares beneficially owned.

Who is the reporting person on the BGMS Form 4?

The reporting person is FITTERS Diversified Berhad, listed as a director; the form was signed by Datuk Tan Chor How Christopher on 10/10/2025.

How does this sale affect insider ownership in BGMS?

The sale reduced the insider's direct holding by 142,000 shares to a remaining 557,158 shares, modestly increasing the public float.

Was the Form 4 filed jointly or by one person?

The filing indicates it was submitted by one reporting person (individual filing).

Does the Form 4 show any derivative transactions?

No derivative securities are listed; the filing only discloses a non-derivative common stock sale.